期刊文献+

润肤止痒乳对银屑病患者角质形成细胞增殖和VEGF分泌的影响 被引量:3

For patients with psoriasis skin itching milk cutin cell proliferation and formed the secretion of VEGF influence
下载PDF
导出
摘要 目的:观察润肤止痒乳对银屑病患者角质形成细胞增殖和VEGF分泌的影响。方法:对银屑病患者表皮角质形成细胞进行原代培养,通过四甲基偶氮唑蓝微量酶反应比色法(MTT法)及酶联免疫吸附法(ELISA)体外观察润肤止痒乳对表皮角质形成细胞增殖及VEGF分泌的影响。结果:润肤止痒乳在0-485.5 mg/mL浓度范围内对角质形成细胞无毒副作用,在该浓度范围内有明显抑制角质形成细胞增殖的作用,其抑制作用与他扎罗汀比较,差异无统计学意义(P>0.05);且在该浓度范围内润肤止痒乳可减少角质形成细胞分泌VEGF的含量。结论:润肤止痒乳在一定浓度范围内可抑制角质形成细胞的增殖作用,且能减少VEGF的分泌。 Objective: To observe the itching for patients with psoriasis skin breast cell proliferation and VEGF cutin form the secretion of influence. Methods: The patients with psoriasis skin cutin form cells for the training, through the four methyl azo blue trace enzyme reaction was colorimetric method (MTT method) and ELISA method (ELISA) in vitro observation of embellish skin itching breast cell proliferation of epidermis cutin formation and the influence of VEGF secretion. Result: Skin itching milk in 0-485.5 mg/mL concentration range form cells to cutin no side effect, in this concentration worldwide significant inhibitory cutin form cell proliferation function, its inhibition and his firm LuoTing comparison, the difference was not statistically significant (P〉0.05); And in this concentration range of embellish skin itching milk can reduce eutin form cells secrete VEGF content. Conclusion: Skin itching milk in a certain concentration range can inhibit cutin form cell proliferation effect, and can reduce the secretion of VEGF.
出处 《中医药导报》 2012年第5期75-78,共4页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 湖南省自然科学基金项目(10JJ6039)
关键词 润肤止痒乳 角质形成细胞 细胞增殖 血管内皮生长因子 Skin itching milk Cutin form cells Cell proliferation Vascular endothelial growth factor
  • 相关文献

参考文献7

二级参考文献18

  • 1[1]Brown LF, Yeo KT, Berse B, et al. Expression of vascular permeability factor(vascular endothelial growth factor) by epidermal keratinocytes during wound healing[J]. J Exp Med, 1992,76: 1375.
  • 2[2]Brown LF, Harrist TJ, Yeo KT, et al. Increased expression of vascular permeability factor(vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme [J]. Jnv Dermatol, 1995,104: 744.
  • 3[3]Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor and its receptors in psoriasis[J]. J Exp Med, 1994,180:1141.
  • 4[1]Chandraratna RA. Tazarotene--first of a new generation of receptor-selective retinoids[J]. Br J Dermatol, 1996, 135 (Suppl 49):18-25.
  • 5[2]Weinstein GD, Krueger GG, Lowe NJ, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect [J]. J Am Acad Dermatol, 1997,37(1): 85-92.
  • 6[3]Pietenpol JA, Stein RW, Moran E, et al. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains [J]. Cell,1990,61(5):777-785.
  • 7[4]Smith EL, Walworth NC, Holick MF. Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions[J]. J Invest Dermatol, 1986,86(6):709-714.
  • 8[5]Wilkinson DI,Theeuwes M J, Farber EM .Never growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes:a comparison with epidermal growth factor [J].Exp Dermatol, 1994,3(5):239-245.
  • 9[6]Nagpal S, Patel S, Asano AT,et al.Tazarotene-induced gene 1(TIG1), a novel retinoic acid receptor-responsive gene in skin [J].J Invest Dermatol,1996,106(2): 269-274.
  • 10[7]Nagpal S,Patel S, Jacobe H,et al. Tazarotene-induced gene 2(TIG2), a novel retinoid-responsive gene in skin [J]. J Invest Dermatol, 1997,109(1): 91-95.

共引文献19

同被引文献31

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部